| 1351. Predictors of Loss of Infectivity Among Healthcare Workers with Primary and Recurrent SARS-CoV-2 infection: An Observational Cohort Study S Dzieciolowska, Y Longtin, H Charest, T Roy, J Fafard, I Levade, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1188, 2023 | | 2023 |
| 2017/18 and 2018/19 seasonal influenza vaccine safety surveillance, Canadian National Vaccine Safety (CANVAS) Network JA Bettinger, G De Serres, L Valiquette, OG Vanderkooi, JD Kellner, ... Eurosurveillance 25 (22), 1900470, 2020 | 15 | 2020 |
| A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses A Tauzin, SY Gong, D Chatterjee, S Ding, MM Painter, RR Goel, ... Cell reports 41 (4), 2022 | 16 | 2022 |
| A Mix-and-match COVID-19 Vaccination Strategy in Patients with Rheumatic Diseases on Rituximab N Amiable, M Benlarbi, M Dube, S Theriault, A Godbout, AS Julien, ... ARTHRITIS & RHEUMATOLOGY 75, 533-536, 2023 | | 2023 |
| A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine. V Gilca, C Sauvageau, G De Serres Vaccine 37 (32), 4422-4423, 2019 | 1 | 2019 |
| A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection Z Naveed, C Chu, M Tadrous, AA Veroniki, J Li, I Rouleau, Y Febriani, ... Heliyon 10 (5), 2024 | | 2024 |
| A nationwide survey of past hepatitis A infections among Canadian adults DW Scheifele, G De Serres, V Gilca, B Duval, R Milner, M Ho, JJ Ochnio Vaccine 28 (32), 5174-5178, 2010 | 14 | 2010 |
| A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season DM Skowronski, C Chambers, S Sabaiduc, G De Serres, AL Winter, ... Clinical Infectious Diseases 63 (1), 21-32, 2016 | 214 | 2016 |
| A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection SA Halperin, R Bortolussi, JM Langley, BJ Eastwood, G De Serres Pediatrics 104 (4), e42-e42, 1999 | 89 | 1999 |
| A review of interventions triggered by hepatitis A infected food-handlers in Canada AC Tricco, B Pham, B Duval, G De Serres, V Gilca, L Vrbova, ... BMC Health Services Research 6, 1-7, 2006 | 41 | 2006 |
| A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010–2011 season DM Skowronski, NZ Janjua, G De Serres, AL Winter, JA Dickinson, ... Clinical infectious diseases 55 (3), 332-342, 2012 | 126 | 2012 |
| A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Biorxiv, 2021.03. 18.435972, 2021 | 47 | 2021 |
| A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccine M Rochette, G De Serres, P Duclos, D Bolduc, P Jutras, S Gamache, ... Vaccine 17 (5), 448-453, 1999 | | 1999 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 161 | 2021 |
| Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine G Deceuninck, C Sauvageau, V Gilca, N Boulianne, G De Serres Expert Review of Vaccines 17 (1), 99-102, 2018 | 24 | 2018 |
| Active Surveillance of Adverse Events Following Immunization Among Healthcare Workers Immunized With the Influenza Vaccine G De Serres, L Valiquette, J Bettinger, G Stiver, A McGeer, A McCarthy, ... | | |
| Administration d’une dose de vaccin bivalent aux personnes vaccinées avec le vaccin monovalent contre la COVID-19 depuis le 15 août 2022 C sur l'immunisation du Québec, G De Serres INSPQ: Institut national de santé publique du Québec, 2022 | | 2022 |
| Administration of COVID-19 booster doses: Recommendations for winter and spring 2023 C sur l'immunisation du Québec, G De Serres INSPQ: Institut national de santé publique du Québec, 2023 | | 2023 |
| Adverse events after vaccination with DTAP in high school students who have previously been vaccinated with D2T5. M Tremblay, JL Grenier, G Serres, S Menard, E Toth, R Roussel, H Favron, ... | 2 | 2006 |
| Adverse events associated with 2010 CSL and other inactivated influenza vaccines. HA Kelly, DM Skowronski, G De Serres, PV Effler Medical Journal of Australia 195 (6), 2011 | 30 | 2011 |
